Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

MDGL

Market Cap$6.64B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Madrigal Pharmaceuticals IncMadrigal Pharmaceuticals Inc-16.9--54%23.7-
$420.00

Target Price by Analysts

36.1% upsideMadrigal Pharmaceuticals Target Price DetailsTarget Price
$154.95

Current Fair Value

49.8% downside

Overvalued by 49.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.64 Billion
Enterprise Value$6.45 Billion
Dividend Yield$0 (0%)
Earnings per Share$-21.9
Beta-1.08
Outstanding Shares22,091,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-16.86
PEG33.48
Price to Sales23.74
Price to Book Ratio9.64
Enterprise Value to Revenue21.31
Enterprise Value to EBIT-16.37
Enterprise Value to Net Income-17
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Madrigal Pharmaceuticals Inc

CEO: Rebecca Taub